Lavipharm SA operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lavipharm SA with three other
pharmaceutical manufacturers in Europe:
New Nordic Healthbrands AB
sales of 452.61 million Swedish Kronor [US$51.15 million]
Science In Sport Plc
of UNITED KINGDOM
(£50.57 million [US$64.84 million]
of which 51%
was PhD), and
Venture Life Group plc
based in UNITED KINGDOM
(£20.21 million [US$25.91 million]
of which 67%
was Customer Brands).
Lavipharm SA reported sales of 33.59 million Euro (US$39.52 million)
December of 2019.
decrease of 1.4%
versus 2018, when the company's sales were 34.06 million Euro.